SCHEMBL10121785

SCHEMBL10121785

CCN(CC)CCCS(=O)(=O)N(Cc1ccc(OC)cc1)Cc1nc(CNC(=O)N2CCCCC2)n[nH]1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BMP1 P13497 2/20 0.37
GHSR Q92847 1/20 0.37
PKM P14618 3/20 0.37
MLLT1 Q03111 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
MAPT P10636 2/20 0.34
TP53 P04637 1/20 0.34
OPRM1 P35372 1/20 0.34
OPRK1 P41145 1/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
USP2 O75604 1/20 0.34
LMNA P02545 1/20 0.34
NPC1 O15118 1/20 0.34
GFER P55789 1/20 0.34
CNR2 P34972 1/20 0.34
NPSR1 Q6W5P4 1/20 0.33
HRH3 Q9Y5N1 1/20 0.33
ALOX15 P16050 1/20 0.33
HTT P42858 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1709736 0.85 KDM4E (0.38) GHSRMLLT1MEN1KMT2ASMN1; SMN2
SCHEMBL1709641 0.78 BCHE (0.36) CNR2HRH3
SCHEMBL1709540 0.71 GHSR (0.57) BMP1GHSRMEN1KMT2AUSP2
SCHEMBL1709571 0.71 GHSR (0.43) GHSRMLLT1KMT2AMAPTSMN1; SMN2
SCHEMBL1709663 0.69 GHSR (0.58) GHSRMLLT1MEN1KMT2AMAPT
SCHEMBL1709537 0.68 GHSR (0.63) BMP1GHSRKMT2AMAPTLMNA
SCHEMBL19812390 0.63 APLNR (0.58) BMP1MAPTLMNACNR2HRH3
SCHEMBL22553416 0.62 HRH3 (0.56) MEN1KMT2AMAPTLMNAHRH3
SCHEMBL25281178 0.62 APLNR (0.59) BMP1
SCHEMBL19285058 0.62 APLNR (0.59) BMP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120088747-A1 SULFONAMIDE CONTAINING COMPOUNDS AND USES THEREOF ELIXIR PHARMACEUTICALS, INC. 2012-04-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120088747-A1 SULFONAMIDE CONTAINING COMPOUNDS AND USES THEREOF GHSR, GHRHR, STS BMP1 2622/4885GHSR 1/4885PKM 2672/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.